SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Zota Health Care gets registration licenses for two products in Myanmar

04 Sep 2024 Evaluate

Zota Health Care has received registration licenses for two products from the Ministry of Health Department of Food and Drug Administration, Myanmar. The company has received registration licenses for LANZOCID-30 (Each hard gelatin capsule contains: Lansoprazole USP 30mg (as enteric coated pellets) and S-AMLOZED 2.5 (Each uncoated tablet contains: S-Amlodipine Besilate eq. to S-Amlodipine 2.5mg).

The company has received said product registration licenses for the validity period of five years; further the same can be renewed after expiration. The company shall commence export of these products in Myanmar in a near term.

Zota Health Care manufactures and markets pharmaceutical formulations, nutraceutical, and ayurvedic medicines in India and internationally. 


Peers
Company Name CMP
Redington 220.95
Adani Enterprises 2088.20
Amrapali Industries 17.32
Rashi Peripheral 404.30
PDS 295.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×